MedTech Acquisitions And Store Expansion Expected To Drive Future Success

Published
09 Feb 25
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
NZ$40.17
2.4% overvalued intrinsic discount
07 Aug
NZ$41.15
Loading
1Y
14.0%
7D
2.7%

Author's Valuation

NZ$40.2

2.4% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 1.84%

Shared on23 Apr 25
Fair value Increased 1.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 0.72%

AnalystConsensusTarget has increased revenue growth from 3.6% to 4.1%.

Shared on09 Apr 25
Fair value Increased 0.65%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 1.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.52%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 1.94%

AnalystConsensusTarget has decreased revenue growth from 4.1% to 3.3%.

Shared on12 Mar 25
Fair value Decreased 0.73%